GLENVIEW CAPITAL MANAGEMENT LLC 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-13 4:39 pm Purchase | 2026-01-06 | 13G | MYRIAD GENETICS INC MYGN | GLENVIEW CAPITAL MANAGEMENT LLC | 4,941,058 5.300% | 3,679,528 (+291.67%) | Filing |
| 2024-11-14 4:16 pm Sale | 2024-09-30 | 13G | MYRIAD GENETICS INC MYGN | GLENVIEW CAPITAL MANAGEMENT LLC | 1,261,530 1.390% | -4,022,452 (-76.13%) | Filing |
| 2024-02-14 4:47 pm Purchase | 2023-12-31 | 13G | MYRIAD GENETICS INC MYGN | GLENVIEW CAPITAL MANAGEMENT LLC | 5,283,982 5.970% | 971,851 (+22.54%) | Filing |
| 2023-03-01 4:10 pm Purchase | 2023-02-24 | 13G | MYRIAD GENETICS INC MYGN | GLENVIEW CAPITAL MANAGEMENT LLC | 4,312,131 5.310% | 4,312,131 (New Position) | Filing |